Advanced capability for translational medicines manufacturing
Located within the University of Strathclyde, CMAC’s National Facility is a purpose-built 900m2 environment providing access to future-ready technologies, specialist expertise, and integrated digital systems.
-
CMAC is a publicly funded national research centre, not a contract research organisation. That distinction matters. When you work with us, you're not buying analytical time — you're accessing a multidisciplinary scientific community that will help you understand why your process behaves the way it does, and how to design it better from the outset.
-
We deliver agile, data‑driven solutions through advanced facilities, integrated digital tools and specialist expertise, providing flexible, end‑to‑end support that accelerates high‑quality, efficient medicines development.
-
We collaborate with organisations of all sizes, academic institutions, technology developers and innovation partners.
A different kind of research partner
Transforming medicines development from molecule to market
We deliver agile, data-driven R&D supporting discovery, particle engineering, crystallisation, formulation development, continuous drug product manufacturing and advanced analytics.
Our approach integrates digital CMC principles — real-time data capture, model-informed development, AI/ML tools, and connected knowledge graph infrastructure — to transition laboratory concepts into industrially relevant processes that support faster, safer, and more flexible medicines manufacturing.
Core capabilities
-
Taking continuous manufacturing from synthesis to final form - reducing cycle times, improving consistency and enabling real-time quality control.
-
Our digital CMC infrastructure is designed to make your results more valuable over time: structured, connected and ready to power AI-enabled pharmaceutical development.
-
Targeted analytical, modelling and process-design grounded in digital CMC, enabling predictive control and accelerated process understanding.
Engagement pathways
-
End-to-end R&D for complex pharmaceutical development challenges.
-
Hands-on use of our technology platforms with expert technical support.
-
Targeted analytics, modelling, troubleshooting and specialist expertise on demand.
Our research and consultancy services span the full development pipeline:
-
X-Ray Diffraction and Solid State Characterisation
With expertise spanning powder and single-crystal diffraction, spectroscopy, imaging and advanced solid-state analysis, CMAC provides comprehensive structural characterisation solutions for pharmaceutical and advanced materials development.
-
Drug Product
With 30+ validated predictive modelling tools, bespoke equipment, and expertise across secondary manufacturing, we enable faster, more confident decisions, from first milligram to commercial scale.
-
Crystallisation
From early-stage screening to continuous manufacturing, CMAC's crystallisation team delivers rapid, model-informed process development, giving you reliable control of particle size, polymorph, and yield with minimal material investment.
-
Nanomedicine
Page coming soon. Contact us to learn about our nanomedicine capabilities.
-
Analytics
Page coming soon. Contact us to learn about our analytical capabilities.
Why work with CMAC?
-
End-to-End Support
Integrated services across drug substance, drug product, and analytics under one roof.
-
Industry-aligned research
Co-created with global pharmaceutical partners, directly aligned to real manufacturing challenges.
-
Accelerated development
Streamlined, data-driven workflows and digital tools get you to market faster with fewer experiments.
-
Proven track record
A strong history of solving complex industrial challenges with global pharmaceutical partners.
-
Multidisciplinary expertise
Chemistry, pharmaceutics, engineering, analytics and modelling experts, working as one team.
-
Flexible access
Engage with us on your terms, whether it's full project delivery, technical consultancy, or one-off support.
From molecule to market customer stories
Discovery to Particle Engineering:
“CMAC’s particle engineering support accelerated our API readiness, giving us material suitable for continuous processing far earlier than expected.”
— Former CustomerFormulation & Continuous Processing:
“The continuous direct compression expertise at CMAC significantly improved our material performance and reduced development cycle times.”
— Former CustomerDigital CMC & Analytics:
“The digital workflows and model‑informed approaches helped us identify optimal operating conditions with far fewer experiments.”
— Former CustomerReady to collaborate?
